CY1122935T1 - Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο - Google Patents
Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονοInfo
- Publication number
- CY1122935T1 CY1122935T1 CY20201100399T CY201100399T CY1122935T1 CY 1122935 T1 CY1122935 T1 CY 1122935T1 CY 20201100399 T CY20201100399 T CY 20201100399T CY 201100399 T CY201100399 T CY 201100399T CY 1122935 T1 CY1122935 T1 CY 1122935T1
- Authority
- CY
- Cyprus
- Prior art keywords
- glycogen
- water solubility
- based water
- solubility enhancer
- complexes
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008137 solubility enhancer Substances 0.000 title 1
- 229920002527 Glycogen Polymers 0.000 abstract 2
- 229940096919 glycogen Drugs 0.000 abstract 2
- 150000002634 lipophilic molecules Chemical class 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13162453 | 2013-04-05 | ||
| PCT/EP2014/056451 WO2014161815A1 (en) | 2013-04-05 | 2014-03-31 | Glycogen-based water solubility enhancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122935T1 true CY1122935T1 (el) | 2021-10-29 |
Family
ID=48049850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20201100399T CY1122935T1 (el) | 2013-04-05 | 2020-04-30 | Ενισχυτικα της υδατοδιαλυτοτητας που βασιζονται στο γλυκογονο |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US10662259B2 (enExample) |
| EP (1) | EP2981557B1 (enExample) |
| JP (1) | JP6312801B2 (enExample) |
| KR (1) | KR102113707B1 (enExample) |
| CN (1) | CN105143274B (enExample) |
| AR (1) | AR095937A1 (enExample) |
| AU (1) | AU2014247145B2 (enExample) |
| BR (1) | BR112015024825A2 (enExample) |
| CA (1) | CA2905273A1 (enExample) |
| CY (1) | CY1122935T1 (enExample) |
| DK (1) | DK2981557T3 (enExample) |
| EA (1) | EA032500B1 (enExample) |
| ES (1) | ES2786900T3 (enExample) |
| GE (1) | GEP201706742B (enExample) |
| HR (1) | HRP20200693T1 (enExample) |
| HU (1) | HUE049561T2 (enExample) |
| IL (1) | IL241690B (enExample) |
| LT (1) | LT2981557T (enExample) |
| MX (1) | MX369778B (enExample) |
| PL (1) | PL2981557T3 (enExample) |
| PT (1) | PT2981557T (enExample) |
| RS (1) | RS60506B1 (enExample) |
| SG (2) | SG11201507932RA (enExample) |
| SI (1) | SI2981557T1 (enExample) |
| SM (1) | SMT202000216T1 (enExample) |
| UA (1) | UA119441C2 (enExample) |
| WO (1) | WO2014161815A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102214865B1 (ko) | 2013-04-26 | 2021-02-15 | 마이렉서스 바이오테크놀로지스 인코퍼레이티드 | 파이토글리코겐 나노입자와 이를 제조하는 방법 |
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| US11508407B2 (en) * | 2018-03-30 | 2022-11-22 | Sony Corporation | Magnetic recording medium having controlled dimensional characteristics |
| US20220047506A1 (en) | 2020-08-12 | 2022-02-17 | Villya LLC | Praziquantel Formulations |
| WO2024158694A1 (en) | 2023-01-23 | 2024-08-02 | Villya LLC | Compositions and methods for improving the solubility of erectile dysfunction therapeutics |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1514720A (en) * | 1974-10-07 | 1978-06-21 | Secr Defence | Preparation of hydroxyethyl starch |
| US4228277A (en) * | 1979-02-12 | 1980-10-14 | Hercules Incorporated | Modified nonionic cellulose ethers |
| IT1255488B (it) | 1992-08-04 | 1995-11-06 | Angelini Francesco Ist Ricerca | Polisaccaridi del glicogeno |
| US5607839A (en) * | 1993-07-22 | 1997-03-04 | Nippon Oil Company, Ltd. | Bacteria belonging to new genus process for production of carotenoids using same |
| US6248361B1 (en) * | 1999-02-26 | 2001-06-19 | Integ, Ltd. | Water-soluble folic acid compositions |
| PT1421120E (pt) * | 2001-08-22 | 2007-08-03 | Supramol Parenteral Colloids | Amilopectina hiper-ramificada para utilização em métodos para o tratamento cirúrgico ou terapêutico de mamíferos ou em métodos de diagnóstico especilamente para utilização como um dilatador do volume de plasma |
| DE10237442B4 (de) * | 2002-08-16 | 2004-08-19 | Fresenius Kabi Deutschland Gmbh | Hochverzweigte, niedrig substituierte Stärkeprodukte |
| US7446101B1 (en) | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
| WO2006040335A1 (en) * | 2004-10-15 | 2006-04-20 | Danisco A/S | A derivatized highly branched polysaccharide and a mix for production of polyurethane thereof |
| US7781572B2 (en) | 2005-10-05 | 2010-08-24 | Nse Products, Inc. | Nanosized carotenoid cyclodextrin complexes |
| US8613946B2 (en) * | 2006-12-21 | 2013-12-24 | Isp Investment Inc. | Carotenoids of enhanced bioavailability |
| US8323615B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
| US9315715B2 (en) * | 2009-10-20 | 2016-04-19 | Nalco Company | Method of reducing the viscosity of hydrocarbons |
| US8901092B2 (en) * | 2010-12-29 | 2014-12-02 | Surmodics, Inc. | Functionalized polysaccharides for active agent delivery |
| RS58985B1 (sr) | 2012-03-15 | 2019-08-30 | Acraf | Katjonski polimeri na bazi glikogena |
| FR2989001B1 (fr) * | 2012-04-06 | 2017-07-21 | Centre Nat Rech Scient | Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine |
-
2014
- 2014-03-28 AR ARP140101413A patent/AR095937A1/es active IP Right Grant
- 2014-03-31 SI SI201431559T patent/SI2981557T1/sl unknown
- 2014-03-31 UA UAA201509813A patent/UA119441C2/uk unknown
- 2014-03-31 HU HUE14713507A patent/HUE049561T2/hu unknown
- 2014-03-31 ES ES14713507T patent/ES2786900T3/es active Active
- 2014-03-31 HR HRP20200693TT patent/HRP20200693T1/hr unknown
- 2014-03-31 CA CA2905273A patent/CA2905273A1/en not_active Abandoned
- 2014-03-31 EP EP14713507.3A patent/EP2981557B1/en active Active
- 2014-03-31 US US14/780,423 patent/US10662259B2/en not_active Expired - Fee Related
- 2014-03-31 WO PCT/EP2014/056451 patent/WO2014161815A1/en not_active Ceased
- 2014-03-31 LT LTEP14713507.3T patent/LT2981557T/lt unknown
- 2014-03-31 BR BR112015024825A patent/BR112015024825A2/pt not_active Application Discontinuation
- 2014-03-31 PL PL14713507T patent/PL2981557T3/pl unknown
- 2014-03-31 KR KR1020157030658A patent/KR102113707B1/ko not_active Expired - Fee Related
- 2014-03-31 GE GEAP201413971A patent/GEP201706742B/en unknown
- 2014-03-31 MX MX2015013739A patent/MX369778B/es active IP Right Grant
- 2014-03-31 EA EA201591860A patent/EA032500B1/ru not_active IP Right Cessation
- 2014-03-31 SM SM20200216T patent/SMT202000216T1/it unknown
- 2014-03-31 DK DK14713507.3T patent/DK2981557T3/da active
- 2014-03-31 SG SG11201507932RA patent/SG11201507932RA/en unknown
- 2014-03-31 AU AU2014247145A patent/AU2014247145B2/en not_active Ceased
- 2014-03-31 SG SG10201708099YA patent/SG10201708099YA/en unknown
- 2014-03-31 RS RS20200457A patent/RS60506B1/sr unknown
- 2014-03-31 PT PT147135073T patent/PT2981557T/pt unknown
- 2014-03-31 JP JP2016505785A patent/JP6312801B2/ja active Active
- 2014-03-31 CN CN201480018127.4A patent/CN105143274B/zh not_active Expired - Fee Related
-
2015
- 2015-09-17 IL IL241690A patent/IL241690B/en active IP Right Grant
-
2020
- 2020-04-30 CY CY20201100399T patent/CY1122935T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122966T1 (el) | 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου | |
| CY1124436T1 (el) | Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια | |
| CY1124928T1 (el) | Αναστολεις πυραζολυλο κινοξαλινο κινασης | |
| CY1126518T1 (el) | Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης | |
| CY1124007T1 (el) | Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης | |
| CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1120730T1 (el) | Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1 | |
| CY1120529T1 (el) | Προφαρμακα φουμαρικων αλατων και η χρηση τους στην αγωγη ποικιλων νοσων | |
| CY1123953T1 (el) | Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης | |
| CY1122329T1 (el) | Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων | |
| CY1120969T1 (el) | Παραγωγα κινοξαλινης χρησιμα ως τροποποιητες fgfr κινασης | |
| CY1122796T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων | |
| CY1121736T1 (el) | Άλατα aramchol | |
| CY1119058T1 (el) | Ενωσεις ιμιδαζοπυρρολιδινονης | |
| CY1124425T1 (el) | Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης | |
| EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| CY1123490T1 (el) | Συνθεσεις που προερχονται απο χιτοζανη | |
| CY1125150T1 (el) | Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου | |
| GT201400297A (es) | Nuevos derivados tienopirimidina, un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| MX381017B (es) | Compuestos peptidomiméticos y conjugados anticuerpo-fármaco de estos. | |
| CY1120204T1 (el) | Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο | |
| CY1124529T1 (el) | Ενωσεις λευκοχρυσου λειτουργικοποιημενες με μονομηλεινιμιδιο για θεραπεια καρκινου | |
| CY1120758T1 (el) | Σταθερα στοματικα διαλυματα για συνδυασμενα εφς | |
| CY1121881T1 (el) | Φαρμακοτεχνικη μορφη που περιεχει σταθερη αναλογια ινσουλινης glargine/λιξισενατιδης |